Conmed (CNMD) Change in Account Payables (2010 - 2026)
Conmed's (CNMD) quarterly Change in Account Payables came in at -$4.2 million in Q2 2026, down 174.49% YoY from $5.7 million in Q2 2025, and down 140.53% on a QoQ basis from $10.5 million in Q1 2026.
Conmed (CNMD) Change in Account Payables (2010 - 2026) Analysis & Trends
Conmed (CNMD) has 17 years of Change in Account Payables data on file, last reported at -$4.2 million in Q2 2026.
- Quarterly Change in Account Payables fell 174.49% year-over-year to -$4.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.9 million (down 846.77% YoY) and the FY2025 annual result came in at -$9.7 million, down 166.26% from the prior year.
- Change in Account Payables eased to -$4.2 million in Q2 2026, from $10.5 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $13.0 million in Q1 2024 to a low of -$13.6 million in Q4 2025.
- A 5-year average of $2.2 million and a median of $2.4 million in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 1858.37% — and 2025, when it sank 2053.8%.
- Tracing CNMD's Change in Account Payables over 5 years: stood at -$1.2 million in 2022, then soared by 672.55% to $6.7 million in 2023, then tumbled by 109.41% to -$632000.0 in 2024, then slumped by 2053.8% to -$13.6 million in 2025, then soared by 68.79% to -$4.2 million in 2026.
- The last three Change in Account Payables figures came in at -$4.2 million (Q2 2026), $10.5 million (Q1 2026), and -$13.6 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Conmed | 1.54 Bn | 1.50 Bn | 197.46 Mn | -4.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.25 Mn |
| Jun 30, 2026 | -4.25 Mn |
| Mar 31, 2026 | 10.48 Mn |
| Mar 31, 2026 | 10.48 Mn |
| Dec 31, 2025 | -13.61 Mn |
| Dec 31, 2025 | -13.61 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | -7.32 Mn |
| Mar 31, 2025 | -7.32 Mn |
| Dec 31, 2024 | -632,000.00 |
| Dec 31, 2024 | -632,000.00 |
| Sep 30, 2024 | 2.05 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 301,000.00 |
| Jun 30, 2024 | 301,000.00 |
| Mar 31, 2024 | 13.00 Mn |
| Mar 31, 2024 | 13.00 Mn |